There are also studies conducted on promoter methylation states of 100 genes, including BRCA1, CCND2, BCL2, MDR1, IL10, and TWIST, recorded to understand how alteration between hypermethylation and hypomethylation over time contributes to select breast cancer susceptibility biomarkers [56]. This evidence concerns the gene TWIST1 and breast carcinoma.